Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Sep 28, 2022--
The "Pharmacovigilance Market Research Report by Type (Contract Outsourcing and In-house), Clinical Trial, Method, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
The Global Pharmacovigilance Market size was estimated at USD 6,669.16 million in 2021, USD 7,637.60 million in 2022, and is projected to grow at a CAGR 15.04% to reach USD 15,458.60 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Pharmacovigilance to forecast the revenues and analyze the trends in each of the following sub-markets:
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmacovigilance Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Market Dynamics
Drivers
Restraints
Opportunities
Challenges
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Pharmacovigilance Market, by Type
7. Pharmacovigilance Market, by Clinical Trial
8. Pharmacovigilance Market, by Method
9. Pharmacovigilance Market, by End-user
10. Americas Pharmacovigilance Market
11. Asia-Pacific Pharmacovigilance Market
12. Europe, Middle East & Africa Pharmacovigilance Market
13. Competitive Landscape
14. Company Usability Profiles
15. Appendix
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/f9xbjq
View source version on businesswire.com:https://www.businesswire.com/news/home/20220928005812/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH OTHER SCIENCE GENERAL HEALTH CLINICAL TRIALS RESEARCH SCIENCE PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 09/28/2022 10:56 AM/DISC: 09/28/2022 10:56 AM
http://www.businesswire.com/news/home/20220928005812/en